Key result
Levosimendan represents a notable advance in the field of positive inotropic therapy.
Key points are not available for this paper at this time.
Caution against routine use in critical care; leaves open confirmation via randomized trials.
Department of Medicine Westchester Medical Center/New York Medical College Valhalla, NY *See also p. 2339.
No takes yet. Share an insight, caveat, or question.
William H. Frishman (2003) studied this question. Levosimendan represents a notable advance in the field of positive inotropic therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: